Form 4: Natera Executive Chairman Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Natera's Executive Chairman, Matthew Rabinowitz, sold a portion of his shares through a pre-arranged 10b5-1 trading plan.
Summary
- Matthew Rabinowitz, the Executive Chairman of Natera, Inc., sold shares of common stock on November 25th and 26th, 2024.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 26, 2024.
- A total of 3,990 shares were sold directly by Mr. Rabinowitz at weighted average prices ranging from $163.2485 to $169.94 per share.
- An additional 3,911 shares were sold indirectly by his spouse at weighted average prices ranging from $163.2485 to $169.94 per share.
- Following these transactions, Mr. Rabinowitz directly owns 2,480,684 shares and indirectly owns 84,000 shares through his spouse.
Sentiment
Score: 5
Explanation: The document reports routine share sales by an executive under a pre-arranged plan. This is a neutral event and does not indicate any positive or negative sentiment.
Risks
- Executive share sales can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
This is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, such as those in the biotechnology and healthcare sectors like Illumina (ILMN) and Exact Sciences (EXAS).
- These plans allow executives to sell shares in a pre-determined manner, avoiding accusations of insider trading.
- The reported transactions are typical for executives managing their personal finances and do not indicate any unusual activity compared to industry standards.
Stakeholder Impact
- The share sales may have a minor impact on the stock price, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 08/26/2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 11/25/2024 | Date of the first reported share sales. |
| 11/26/2024 | Date of the second reported share sales. |
| 11/27/2024 | Date the Form 4 was signed. |
Keywords
Natera, NTRA, Executive Chairman, Matthew Rabinowitz, share sale, Form 4, Rule 10b5-1, insider trading, stock transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.